CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea

Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song

Cancer Research and Treatment. 2020;52(4):1229-1241. Published online 2020 July 27 DOI: https://doi.org/10.4143/crt.2020.557

Disparities between Uptake of Germline BRCA1/2 Gene Tests and Implementation of Post-test Management Strategies in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Young Min Hur, Jaehee Mun, Mi-Kyung Kim, Maria Lee, Yun Hwan Kim, Seung-Cheol Kim

Journal of Korean Medical Science. 2021;36(38):

Link1 Link2 Link3

Clinical outcomes of BRCA1/2 pathogenic variants in ovarian cancer cluster region in patients with primary peritoneal, epithelial ovarian, and fallopian tube cancer

Hyeong In Ha, Eun Young Park, Kyung Jin Eoh, Yeon Jee Lee, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park, Myong Cheol Lim

Gynecologic Oncology. 2022;164(2):415-420

Link1 Link2

Evaluation of pemetrexed in the treatment of epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer: a retrospective study

Yanmei Wu, Jie Jiang

. 2020;

Link1 Link2

Somatic and germline genetic testing in advanced ovarian/peritoneal/fallopian tube cancer and pathologic chemotherapy response score (pCRS) after neoadjuvant chemotherapy

C.M. Cosgrove, L. Senter, R. Owda, D.E. Cohn, A.A. Suarez, R. Salani

Gynecologic Oncology. 2019;154:175-176

Link1 Link2

Chemotherapy for epithelial ovarian, fallopian tube and primary peritoneal cancer

Kate Webber, Michael Friedlander

Best Practice & Research Clinical Obstetrics & Gynaecology. 2017;41:126-138

Link1 Link2

Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer

Jonathan S. Berek, Malte Renz, Michael L. Friedlander, Robert C. Bast

Holland‐Frei Cancer Medicine. 2022;1-23

Link1 Link2 Link3

Outpatient Intraperitoneal Chemotherapy for All Stages of Ovarian, Fallopian Tube, and Peritoneal Cancers: A Pilot Study

David Silver, Nadim Bou Zgheib

Clinical Ovarian Cancer. 2011;4(1):7-11

Link1 Link2

Outcomes after successful fallopian tube recanalization: A single institution experience: Observational Retrospective study

Joshua Antranig Marlow, Daniel Picus, Jennifer Gould, Sarah Connolly, Naganathan Bhagvathysubra Mani

Clinical Imaging. 2021;76:70-73

Link1 Link2

Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review

Flora Zagouri, Theodoros Sergentanis, Dimosthenis Chrysikos, Aristotle Bamias, Athanasios-Meletios Dimopoulos

OncoTargets and Therapy. 2015;2187

Link1

Prevalence of germline BRCA1 and BRCA2 mutations and variants among ovarian, primary peritoneal and fallopian tube cancer patients: A multicentre Indian study

S. Gupta, S. Rajappa, S.H. Advani, A. Agarwal, S. Aggarwal, C. Goswami, S. Dattatreya Palanki, D. Arya, S. Patil, R. Kodagali

Annals of Oncology. 2019;30:ix78

Link1 Link2 Link3

Link4

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.